These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15010820)

  • 21. Invasiveness and MMP expression in pancreatic carcinoma.
    Yang X; Staren ED; Howard JM; Iwamura T; Bartsch JE; Appert HE
    J Surg Res; 2001 Jun; 98(1):33-9. PubMed ID: 11368535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J; Wang B
    Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
    You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
    Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel.
    Kuwajima A; Iwashita J; Murata J; Abe T
    Anticancer Res; 2007; 27(6B):4163-9. PubMed ID: 18225587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
    Huang CS; Fan YE; Lin CY; Hu ML
    J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
    Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
    Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes.
    Xia SH; Wang J; Kang JX
    Carcinogenesis; 2005 Apr; 26(4):779-84. PubMed ID: 15661810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis.
    Yang JH; Wu MY; Chen MJ; Chen SU; Yang YS; Ho HN
    Fertil Steril; 2009 May; 91(5 Suppl):2193-8. PubMed ID: 18692810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.
    Wakabayashi K; Saito H; Kaneko F; Nakamoto N; Tada S; Hibi T
    Int J Oncol; 2005 Jan; 26(1):233-9. PubMed ID: 15586245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans.
    Claveau I; Mostefaoui Y; Rouabhia M
    Matrix Biol; 2004 Nov; 23(7):477-86. PubMed ID: 15579314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
    Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
    J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
    Qu X; Yuan Y; Xu W; Chen M; Cui S; Meng H; Li Y; Makuuchi M; Nakata M; Tang W
    Anticancer Res; 2006; 26(5A):3573-8. PubMed ID: 17094485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of matrix metalloproteinases and tissue-derived inhibitors of metalloproteinase in fetal and adult skins.
    Chen W; Fu X; Ge S; Sun T; Sheng Z
    Int J Biochem Cell Biol; 2007; 39(5):997-1005. PubMed ID: 17409012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.
    Kato Y; Yamashita T; Ishikawa M
    Oncol Rep; 2002; 9(3):565-9. PubMed ID: 11956628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases and their inhibitors as biomarkers for metal toxicity in vitro.
    Cammarota M; Lamberti M; Masella L; Galletti P; De Rosa M; Sannolo N; Giuliano M
    Toxicol In Vitro; 2006 Oct; 20(7):1125-32. PubMed ID: 16581223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases.
    Bao BY; Yeh SD; Lee YF
    Carcinogenesis; 2006 Jan; 27(1):32-42. PubMed ID: 15987715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors.
    Di Simone N; Di Nicuolo F; Sanguinetti M; Ferrazzani S; D'Alessio MC; Castellani R; Bompiani A; Caruso A
    Placenta; 2007 Apr; 28(4):298-304. PubMed ID: 16750851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.
    Peng PL; Hsieh YS; Wang CJ; Hsu JL; Chou FP
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):8-15. PubMed ID: 16387334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.